专利信息

首页 1 2 3 4 5 6 下页尾页共 531 条记录, 当前第1/54页。

专利标题：The antineoplastic combinations that contains vegf inhibitor and irinotecan

专利标题：CANCER TREATMENT USING VIRUSES AND CAMPTOTHECINS

Mammalian subjects having a neoplasm are treated with a virus and a camptothecin compound, for example irinotecan or topotecan. The virus is selected from the group consisting of a Newcastle disease virus, a measles virus, a vesicular stomatitis virus, an influenza virus, a Sindbis virus, a picornavirus, and a myxoma virus. The treatment can also include administration of a monoclonal antibody against epidermal growth factor receptor, for example cetuximab.

专利标题：The compositions that comprises vegf trap, folinic acid, 5-fluorouracil (5-fu) and irinotecan (folfiri)

专利标题：Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

专利权人：MERRIMACK PHARMACEUTICALS INC;

METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN 5 Abstract of the Disclosure Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin. - 59 -

专利标题：Irinotecan hydrochloride lipid nanoparticle injection

专利标题：Liposome of irinotecan or its hydrochloride and preparation method thereof

专利标题：METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN

Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.

New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

专利标题：Novel crystal forms of irinotecan hydrochloride

专利权人：Scinopharm Singapore Pte, Ltd.;

The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.

专利标题：Compounds and compositions for the treatment of cancer

专利权人：Prometic Biosciences, Inc.;

当前查询条件: [药品] 包含 'Irinotecan '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103623392A	2014/3/12
专利标题：The antineoplastic combinations that contains vegf inhibitor and irinotecan 专利权人：

2. US2014065140A1	2014/3/6	US201314076485	2013/11/11
专利标题：CANCER TREATMENT USING VIRUSES AND CAMPTOTHECINS 专利权人：WELLSTAT BIOLOGICS CORP [US]; Mammalian subjects having a neoplasm are treated with a virus and a camptothecin compound, for example irinotecan or topotecan. The virus is selected from the group consisting of a Newcastle disease virus, a measles virus, a vesicular stomatitis virus, an influenza virus, a Sindbis virus, a picornavirus, and a myxoma virus. The treatment can also include administration of a monoclonal antibody against epidermal growth factor receptor, for example cetuximab.

3. CN103608029A	2014/2/26
专利标题：The compositions that comprises vegf trap, folinic acid, 5-fluorouracil (5-fu) and irinotecan (folfiri) 专利权人：

4. AU2013202947A1	2014/1/16	AU20130202947	2013/4/8
专利标题：Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan 专利权人：MERRIMACK PHARMACEUTICALS INC; METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN 5 Abstract of the Disclosure Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin. - 59 -

5. CN102697720B	2014/1/15
专利标题：Irinotecan hydrochloride lipid nanoparticle injection 专利权人：Hainan Lingkang Pharmaceutical Co., Ltd.;

6. EP2508170A4	2014/1/15
专利标题：Liposome of irinotecan or its hydrochloride and preparation method thereof 专利权人：Jiangsu Hengrui Medicine Co., Ltd.;

7. WO2013188586A1	2013/12/19	WO2013US45495	2013/6/12
专利标题：METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN 专利权人：MERRIMACK PHARMACEUTICALS INC [US]; Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.

8. JP2013544799A	2013/12/19	JP20130535215	2011/10/26
专利标题：专利权人： New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

9. CA2623117C	2013/12/10
专利标题：Novel crystal forms of irinotecan hydrochloride 专利权人：Scinopharm Singapore Pte, Ltd.; The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.

10. KR20130132448A	2013/12/4	KR20137013238	2011/10/26
专利标题：Compounds and compositions for the treatment of cancer 专利权人：Prometic Biosciences, Inc.; New uses for phenylketone carboxylate compounds and substituted aromatic compounds of Formula I Formula I.1 Formula I.2 Formula IA Formula IB Formula IC and Formula II and their pharmaceutical acceptable salts for the treatment of cancer. The use of a combination of two of these compounds is described and the use of the combination of one of these compounds with an anticancer agent such as decarbazine doxorubicin daunorubicin cyclophosphamide busulfex busulfan vinblastine vincristine bleomycin e...

下载范围

下载内容